Compare Skyworks Solutions Inc (SWKS) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Skyworks Solutions Inc vs GeneDx Holdings Corp — how do they compare? Skyworks Solutions Inc trades at $76.18 (market cap $11.52B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.58B). The key difference: Skyworks Solutions Inc is far larger — about 4.5× GeneDx Holdings Corp's market cap, and Skyworks Solutions Inc pays a 4.13% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| SWKS | WGS | |
|---|---|---|
Market Cap | $11.52B | $2.58B |
Sector | Technology | Technology |
52-Week High | $83.40 | $167.51 |
52-Week Low | $52.50 | $34.51 |
Enterprise Value | $11.40B | $2.61B |
Dividend Yield | 4.13% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Skyworks Solutions (SWKS) trades at $75.38, up 1.84% with bullish technical signals from moving averages. The stock shows strong earnings momentum with three consecutive quarterly beats but faces revenue contraction from $5.5B in 2022 to $4.1B in 2025. Analyst consensus remains positive with 58% buy ratings, though the current price exceeds the $66.44 consensus target. Recent institutional buying and conference participation indicate continued market interest despite ongoing revenue challenges.
The outlook remains cautiously optimistic with AI data center growth providing upside potential, but declining revenue and margin compression present headwinds. Key risks include ongoing fiduciary investigations and competitive pressures in the semiconductor sector. The stock's elevated P/E ratio of 39 requires sustained earnings growth to justify current valuation levels.
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
